Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Kempe

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Inorganic Chemistry|September 18, 2001
[Me3SiN(PPh3)-ICN]: a new labile donor-acceptor complexR Kempe, E Kessenich, A Schulz
Journal of Animal Breeding and Genetics = Zeitschrift Fur Tierzuchtung Und Zuchtungsbiologie|November 19, 2013
Genetic parameters of pelt character, feed efficiency and size traits in Finnish blue fox (Vulpes lagopus)R Kempe, N Koskinen, I Strandén
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 17, 2001
Synthesis and structural characterization of novel silenes stabilized by intramolecular coordination of a dialkylamino groupM Mickoleit, R Kempe, H Oehme
Journal of Forensic Sciences|April 1, 1972
Detection of dynamite residues on the hands of bombing suspectsC R Kempe, W K Tannert
Biochemical Pharmacology|March 1, 1991
Biochemical pharmacology of platelet-activating factor (and PAF antagonists) in relation to clinical and experimental thrombocytopeniaC J Meade, H Heuer, R Kempe
Journal of Animal Breeding and Genetics = Zeitschrift Fur Tierzuchtung Und Zuchtungsbiologie|July 20, 2016
Risk aversion affects economic values of blue fox breeding schemeJ Peura, R Kempe, I Strandén, et al.
Blut|July 1, 1990
Failure of the platelet-activating-factor antagonist WEB 2086 BS for treatment of chronic autoimmune thrombocytopeniaG Giers, H Janzarik, E R Kempe, et al.
Lancet (London, England)|July 21, 1990
PAF-acether-antagonist WEB 2086 for treatment of chronic idiopathic thrombocytopeniaG Giers, H Janzarik, E R Kempe, et al.
Anti-Cancer Drugs|June 1, 1997
Comparison of oral itasetron with oral ondansetron: results of a double-blind, active-controlled phase II study in chemotherapy-naive patients receiving moderately emetogenic chemotherapyH Goldschmidt, H Salwender, G Egerer, et al.
Journal of Dairy Science|February 18, 1999
Genetic parameters for the milk coagulation properties and prevalence of noncoagulating milk in Finnish dairy cowsT Ikonen, K Ahlfors, R Kempe, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Inorganic Chemistry|September 18, 2001
[Me3SiN(PPh3)-ICN]: a new labile donor-acceptor complexR Kempe, E Kessenich, A Schulz
Journal of Animal Breeding and Genetics = Zeitschrift Fur Tierzuchtung Und Zuchtungsbiologie|November 19, 2013
Genetic parameters of pelt character, feed efficiency and size traits in Finnish blue fox (Vulpes lagopus)R Kempe, N Koskinen, I Strandén
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 17, 2001
Synthesis and structural characterization of novel silenes stabilized by intramolecular coordination of a dialkylamino groupM Mickoleit, R Kempe, H Oehme
Journal of Forensic Sciences|April 1, 1972
Detection of dynamite residues on the hands of bombing suspectsC R Kempe, W K Tannert
Biochemical Pharmacology|March 1, 1991
Biochemical pharmacology of platelet-activating factor (and PAF antagonists) in relation to clinical and experimental thrombocytopeniaC J Meade, H Heuer, R Kempe
Journal of Animal Breeding and Genetics = Zeitschrift Fur Tierzuchtung Und Zuchtungsbiologie|July 20, 2016
Risk aversion affects economic values of blue fox breeding schemeJ Peura, R Kempe, I Strandén, et al.
Blut|July 1, 1990
Failure of the platelet-activating-factor antagonist WEB 2086 BS for treatment of chronic autoimmune thrombocytopeniaG Giers, H Janzarik, E R Kempe, et al.
Lancet (London, England)|July 21, 1990
PAF-acether-antagonist WEB 2086 for treatment of chronic idiopathic thrombocytopeniaG Giers, H Janzarik, E R Kempe, et al.
Anti-Cancer Drugs|June 1, 1997
Comparison of oral itasetron with oral ondansetron: results of a double-blind, active-controlled phase II study in chemotherapy-naive patients receiving moderately emetogenic chemotherapyH Goldschmidt, H Salwender, G Egerer, et al.
Journal of Dairy Science|February 18, 1999
Genetic parameters for the milk coagulation properties and prevalence of noncoagulating milk in Finnish dairy cowsT Ikonen, K Ahlfors, R Kempe, et al.
Pageof 3